|
Delayed
Bombay S.E.
08:30:15 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 497.00 INR | -4.42% |
|
+0.18% | +12.88% |
| 08-14 | Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 05-30 | Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 19.51M | - | - | - | - | - |
| 1,224B | |||||
| 662B | |||||
| 514B | |||||
| 388B | |||||
| 361B |
Select your edition
All financial news and data tailored to specific country editions
